STOCK TITAN
  1. Home
  2. Sec-filings
  3. STE
  4. [Form 4] STERIS plc Insider Trading Activity

STERIS plc (STE) director Holland receives 1,025 Career Restricted Stock Units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HOLLAND CHRISTOPHER S reported acquisition or exercise transactions in this Form 4 filing.

STERIS plc director Christopher S. Holland received a grant of 1,025 Career Restricted Stock Units, each representing the right to receive one ordinary share. The units are fully vested immediately and will be settled in ordinary shares six months after his Board service ends. Following this award, he directly holds 5,989 Career Restricted Stock Units.

Positive

  • None.

Negative

  • None.
Insider HOLLAND CHRISTOPHER S
Role Director
Type Security Shares Price Value
Grant/Award Career Restricted Stock Units F1, F2 1,025 $0.00 $0.00
Holdings After Transaction: Career Restricted Stock Units — 5,989 shares (Direct)
Footnotes (2)
  1. F1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
  2. F2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Career Restricted Stock Units granted 1,025 units Grant to director Christopher S. Holland on 2026-08-10
Units held after transaction 5,989 units Total Career Restricted Stock Units directly held after the award
Grant price per unit $0.0000 per unit Stated transaction price for the Career Restricted Stock Unit grant
Underlying ordinary shares per unit 1 share per unit Each Career Restricted Stock Unit represents one STERIS ordinary share
Career Restricted Stock Units financial
"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"
fully vested financial
"These Career Restricted Stock Units are fully vested immediately."
settled in STERIS ordinary shares financial
"They will be settled in STERIS ordinary shares six months after the cessation"

FAQ

What insider transaction did STERIS plc (STE) report for Christopher S. Holland?
STERIS reported that director Christopher S. Holland received a grant of 1,025 Career Restricted Stock Units. These units are compensation-related awards, not market purchases or sales of existing STERIS ordinary shares.

How many STERIS (STE) Career Restricted Stock Units were granted and what do they represent?
Christopher S. Holland was granted 1,025 Career Restricted Stock Units. Each unit represents the right to receive one STERIS ordinary share, to be delivered six months after his Board service ends, according to the award terms.

When do Christopher S. Holland’s STERIS (STE) Career Restricted Stock Units vest and settle?
The Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of Christopher S. Holland’s service on the STERIS Board of Directors.

What is Christopher S. Holland’s STERIS (STE) Career Restricted Stock Unit balance after this grant?
After this grant, Christopher S. Holland directly holds 5,989 Career Restricted Stock Units. This figure reflects his total reported RSU-based rights to receive STERIS ordinary shares as of the transaction date in this filing.

Did Christopher S. Holland buy or sell STERIS (STE) shares on the market in this Form 4?
No market buy or sell is reported. The Form 4 shows a grant/award acquisition of 1,025 Career Restricted Stock Units at a stated price of $0.0000 per unit, reflecting a compensation award rather than a market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOLLAND CHRISTOPHER S
(Last)(First)(Middle)
C/O 70 SIR JOHN ROGERSON'S QUAY
(Street)
DUBLIN 2D02 R296
(City)(State)(Zip)
IRELAND
(Country)		2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Career Restricted Stock Units(1)08/10/2026A1,025 (2) (2)Ordinary Shares1,025$05,989D
Explanation of Responses:
1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Remarks:
/s/ John P. Ubbing, Authorized Representative under Power of Attorney08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR